People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Other Technology, Pharma, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DiCE MOLECULES HOLDINGS, LLC | — | Other Technology | Series C | $158.8M | $1.3B | 2018 |
| Star Therapeutics LLC | — | Pharma | Series D+ | $125.0M | $936.1M | 2025 |
| Pursuant Health, Inc. | — | Healthtech | Series A | $75.5M | $12.7M | 2022 |
Scott Robertson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Scott Robertson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Gordon | 1 | 24 |
| Beth Seidenberg | 1 | 15 |
| Michael Rubin | 1 | 8 |
| Jason Hafler | 1 | 6 |
| Jake Simson | 1 | 6 |
| Maha Katabi | 1 | 6 |
| Nancy Stagliano | 1 | 5 |
| Matthew Fust | 1 | 4 |
| Sharon Tetlow | 1 | 4 |
| Shaan Gandhi | 1 | 4 |
| Richard Scheller | 1 | 4 |
| Stan Blaylock | 1 | 3 |
| John Bedbrook | 1 | 3 |
| Kevin Judice | 1 | 3 |
| Peter Krivkovich | 1 | 2 |
| Brett Moraski | 1 | 2 |
| Chad Terry | 1 | 2 |
| Stephen Kendig | 1 | 2 |
| Michael Daley | 1 | 2 |
| Michael Dailey | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.